Læknablaðið - 15.05.2000, Qupperneq 18

FRÆÐIGREINAR / BARNAGEÐLÆKNINGAR
hyperactivity Symtoms in Iclandic Schoolchildren: Assess-
ment with the Attention Deficit/Hyperactivity Rating Scale-
IV. Scand J Psychol 1999; 40: 301-6.
22. Achenbach T. Integrative Guide for the 1991 CBCL/4-18,
YSR, & TRF Profiles. Burlington, VT: University of Vermont
Department of Psychiatry; 1991.
23. Barkley RA, Edelbrock C. Assessing situational variation in
children's problem behaviours: The Home and School Situa-
tions Questionnaires. In: Prinz RJ, ed. Advances in Behavi-
oural Assessment of Children and Families. Greenwich, CT:
JAI Press Inc.; 1987:157-67.
24. Jensen PS, Bhatara VS, Vitiello B, Hoagwood K, Feil M,
Burke LB. Psychoactive medication prescribing practices for
U.S. children: gaps between research and clinical practice. J
Am Acad Child Adolesc Psychiatry 1999; 38: 557-65.
25. Sergeant JA, Steinhausen H-C. European perspective on
hyperkinetic disorder. Eur Child Adolesc Psychiatry 1992; 1:
34-41.
26. Cyr M, Brown CS. Current drug therapy recommendations for
the treatment of attention deficit hyperactivity disorder.
Drugs 1998; 56: 215-23.
27. Zarin DA, Suarez AP, Pincus HA, Kupersanin E, Zito JM.
Clinical and treatment characteristics of children with atten-
tion-defieit/hyperactivity disorder in psychiatric practice. J
Am Acad Child Adolesc Psychiatry 1998; 37:1262-70.
28. Geller B, Reising D, Leonard HL, Riddle MA, Walsh BT.
Critical review of tricyclic antidepressant use in children and
adolescents. J Am Acad Child Adolesc Psychiatry 1999; 38:
513-6.
29. Lowe TL, Cohen DJ, Detlor J, Kremenitzer MW, Shaywitz
BA. Stimulant medications precipitate tourette's syndrome.
JAMA 1982; 247:1729-31.
30. Barkley RA. The use of psychopharmacology to study recipro-
cal influences in parent-child interaction. J Abnorm Child
Psychol 1981; 9: 303-10.
31. Þorleifsdóttir B, Benediktsdóttir B, Helgason H, Tryggvadóttir
H. Sleep patterns, behavioural symptoms and attention deficits
in a group of Icelandic children with ADHD: preliminary
findings [abstract]. 5th Nordic symposium on ADHD/DAMP.
Reykjavík Iceland, October 8-9,1999.
32. Greenhill LL, Halperin JM, Abikoff H. Stimulant medica-
tions. J Am Acad Child Adolesc Psychiatry 1999; 38: 503-12.
33. Hunt RD, Minderaa RB, Cohen DJ. Clonidine benefits
children with attention deficit disorder and hyperactivity:
report of a double-blind placebo-crossover therapeutic trial. J
Am Acad Child Psychiatry 1985; 24: 617-29.
34. Steingard R, Biederman J, Spencer T, Wilens T, Gonzalez A.
Comparison of clonidine response in the treatment of atten-
tion-deficit hyperactivity disorder with and without comorbidi-
tic disorders. J Am Acad Child Adolesc Psychiatry 1993; 32:
350-3.
35. Connor DF, Fletcher KE, Swanson JM. A meta-analysis of
clonidine for symptoms of attention-deficit hyperactivity dis-
order. J Am Acad Child Adolesc Psychiatry 1999; 38:1551-9.
36. Biederman J, Munir K, Knee D, Habelow W, Armentano M,
Autor S, et al. A family study of patients with attention deficit
disorder and normal controls. J Psychiatr Res 1986; 20:263-74.
37. Barkley RA, DuPaul GJ, McMurray MB. Comprehensive
evaluation of attention deficit disorder with and without
hyperactivity as defined by research criteria. J Consult Clin
Psychol 1990; 58: 775-89.
38. Barkley RA, Biederman J. Toward a broader definition of the
age-of-onset criterion for attention-deficit hyperactivity dis-
order. J Am Acad Child Adolesc Psychiatry 1997; 36:1204-10.
39. Biederman J, Faraone SV, Lapey K. Comorbidity of diagnosis
in attention-deficit hyperactivity disorder: child and adoles-
cent psychiatry clinics in North-America: attention deficit dis-
order. In: Weiss G, ed. Comorbidity of diagnosis in attention-
deficit hyperactivity disorder: child and adolescent psychiatry
clinics in North-America: Attention deficit disorder. Philadel-
phia: W.B. Saunder; 1992:335-60.
40. Loeber R, Green SM, Lahey BB, Christ MAG, Frick PJ. De-
velopmental sequences in the age of onset of disruptive child
behaviors. J Child Fam Stud 1992; 1:21-41.
41. Biederman J, Newcorn J, Sprich S. Comorbidity of attention
deficit hyperactivity disorder with conduct, depressive, anxi-
ety, and other disorders. Am J Psychiatry 1991; 148: 564-77.
42. Biederman J, Munir K, Knee D. Conduct and oppositional
disorder in clinically referred children with attention deficit
disorder: a controlled family study. J Am Acad Child Adolesc
Psychiatry 1987; 26: 724-7.
43. Jensen PS, Kettle L, Roper MT, Sloan MT, Dulcan MK, Hoven
C, et al. Are stimulants overprescribed? Treatment of adhd in
four U.S. communities. J Am Acad Child Adolesc Psychiatry
1999; 38:797-804.
44. World Health Organization. The International Classification
of Diseases, lOth revision. Geneva: WHO; 1992.
45. Jensen PS. Ethical and pragmatic issues in the use of psychotro-
pic agents in young children. Can J Psychiatry 1998; 43: 585-8.
46. Musten LM, Firestone P, Pisterman S, Bennett S, Mercer J. Ef-
fects of methylphenidate on preschool children with adhd:
cognitive and behavioral functions. J Am Acad Child Adolesc
Psychiatry 1997; 36:1407-15.
Fræðigreinar íslenskra
lækna í erlendum
tímaritum
Getið er fræðigreina. Sendið heiti greinar, nöfn höf-
unda og birtingarstaö til Læknablaðsins. Miðað er við
greinar sem birst hafa á yfirstandandi og síðasta ári.
Til glöggvunar verður íslenskra höfunda getið með
fornafni þótt þess sé ekki getið við birtingu.
• Helgi Birgisson, Guðmundur Vikar Einarsson,
Margrét Steinarsdóttir, Jón Gunnlaugur Jónasson.
Metanephric Adenoma. Scand J Urol Nephrol 1999;
33:340-4.
• Ólafur Ólafsson. P. A. Schleisner: A Pioneer in Epi-
demiology. J Clin Epidemiol 1999; 52: 905-7.
X
342 Læknablaðið 2000/86